Torii Pharmaceutical Co., Ltd. revised earnings guidance for the fiscal year ended December 31, 2016. For the year, the company expected net sales of JPY 60,200 million against previous forecast of JPY 60,500 million, operating income of JPY 3,810 million against previous forecast of JPY 3,000 million, ordinary income of JPY 3,990 million against previous forecast of JPY 3,100 million, net income of JPY 2,770 million against previous forecast of JPY 2,100 million and net income per share JPY 97.94 against previous forecast of JPY 74.21.